Oregon State Public Health Laboratory Participation in the FDA NARMS Retail Meat Program

俄勒冈州公共卫生实验室参与 FDA NARMS 零售肉类计划

• 批准号: 9768173
• 负责人: John L Fontana
• 金额: $ 14万
• 依托单位: PUBLIC HEALTH SERVICES
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-01 至 2020-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9768173
• 关键词: Oregon; State; Public; Health; Laboratory

Oregon State Public Health Laboratory FDA NARMS Retail Meat Program Summary/Abstract The Oregon State Public Health Laboratory (OSPHL) plans to continue participation in the Food and Drug Administration (FDA) National Antimicrobial Resistance Monitoring System (NARMS) Retail Meat Program to provide information from active surveillance of retail meat products for microorganisms that cause foodborne illness to support epidemiological investigation and response locally and nationally. The mission of the OSPHL is to protect the health and safety of Oregonians and provide surveillance of retail meats for specific pathogens to support this goal. The OSPHL will purchase up to 80 retail meat samples per month in the metropolitan Portland area and identify bacterial isolates with microbial culture techniques. The OSPHL will send isolates of Salmonella spp., Campylobacter spp., Enterococcus spp., and Escherichia coli for antimicrobial resistance testing at the FDA. Timely information on bacterial loads on retail meat and further characterization of Salmonella spp. at the OSPHL will allow our Oregon state epidemiologists to initiate the appropriate public health response for foodborne illness outbreaks. Additional information on antimicrobial resistance may direct treatment of human cases and indicate trends to allow epidemiological intervention and evaluation of health risk. The OSPHL has participated in the FDA NARMS Retail Meat Program since 2002. We will continue to purchase retail meat products as directed by the FDA sampling program and process the meat samples utilizing the FDA protocols. All Salmonella isolates will be serotyped and characterized by pulsed filed gel electrophoresis at the OSPHL to provide comparative information with human isolates. Antimicrobial resistance testing will be performed on all isolates at the FDA and all data will be shared with state partners.

俄勒冈州公共卫生实验室 FDA NARMS零售肉类计划摘要/摘要 俄勒冈州公共卫生实验室（OSPHL）计划继续参与 美国食品药品监督管理局（FDA）国家抗菌素耐药性监测 系统（NARMS）零售肉类计划，以提供来自主动监测的信息 零售肉制品中导致食源性疾病的微生物， 地方和国家的流行病学调查和应对措施。联合国的使命 OSPHL是为了保护俄勒冈人的健康和安全，并提供监测， 零售肉类的特定病原体，以支持这一目标。OSPHL将购买多达 每月在大都会波特兰地区抽取80份零售肉类样本， 细菌分离物与微生物培养技术。OSPHL将把分离的 沙门氏菌属，弯曲杆菌属，肠球菌属，和大肠杆菌， 在食品药品监督管理局进行抗菌药物耐药性测试及时提供细菌负荷信息 零售肉类和沙门氏菌属的进一步表征。在OSPHL将允许我们的 俄勒冈州流行病学家发起适当的公共卫生反应， 食源性疾病暴发。关于抗菌素耐药性的其他信息可能 直接治疗人间病例，并指出流行病学趋势， 健康风险干预与评价。OSPHL参加了FDA 自2002年以来，NARMS零售肉类计划。我们将继续购买零售肉类 按照FDA抽样计划的指示生产产品并处理肉类样本 使用FDA协议。将对所有沙门氏菌分离株进行血清分型和表征 通过OSPHL的脉冲场凝胶电泳提供比较信息 与人类分离株。将对所有分离株进行抗菌药物耐药性试验， FDA和所有数据将与国家合作伙伴共享。